FFA
IDNA icon

Founders Financial Alliance’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Founders Financial Alliance’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.1K Hold
3,412
– – 0.02% 453
2025
Q4 		$89.4K Buy
3,412
+12
+0.4% +$309 0.02% 401
2025
Q3 		$80.3K Buy
+3,400
New +$75.2K 0.02% 455

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Founders Financial Alliance's IDNA Position: Q1 2026 in Review

Founders Financial Alliance held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q1 2026 at 3,412 shares worth $99.1K. The position accounts for 0.02% of the portfolio, ranked #453.

Founders Financial Alliance first reported a position in IDNA in Q3 2025 and has held it in 3 quarters since. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Founders Financial Alliance held 3,412 shares of iShares Genomics Immunology and Healthcare ETF worth $99.1K as of Q1 2026.
  • Founders Financial Alliance left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q1 2026.
  • iShares Genomics Immunology and Healthcare ETF made up 0.02% of Founders Financial Alliance's portfolio in Q1 2026, its #453 holding.
  • Founders Financial Alliance first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2025 and has held it in 3 quarters since.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Founders Financial Alliance's 13F filing for Q1 2026, filed 11 May 2026.